- Home
- GRNQ vs CLRB Comparison
GRNQ vs CLRB Comparison
Compare GRNQ & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRNQ
- CLRB
- Stock Information
- Founded
- GRNQ 2013
- CLRB 2002
- Country
- GRNQ Malaysia
- CLRB United States
- Employees
- GRNQ N/A
- CLRB N/A
- Industry
- GRNQ EDP Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- GRNQ Technology
- CLRB Health Care
- Exchange
- GRNQ Nasdaq
- CLRB Nasdaq
- Market Cap
- GRNQ 12.1M
- CLRB 12.8M
- IPO Year
- GRNQ 2018
- CLRB N/A
- Fundamental
- Price
- GRNQ $1.67
- CLRB $2.88
- Analyst Decision
- GRNQ
- CLRB Hold
- Analyst Count
- GRNQ 0
- CLRB 2
- Target Price
- GRNQ N/A
- CLRB N/A
- AVG Volume (30 Days)
- GRNQ 56.1K
- CLRB 90.4K
- Earning Date
- GRNQ 11-13-2025
- CLRB 11-13-2025
- Dividend Yield
- GRNQ N/A
- CLRB N/A
- EPS Growth
- GRNQ N/A
- CLRB N/A
- EPS
- GRNQ N/A
- CLRB N/A
- Revenue
- GRNQ $3,110,208.00
- CLRB N/A
- Revenue This Year
- GRNQ N/A
- CLRB N/A
- Revenue Next Year
- GRNQ N/A
- CLRB N/A
- P/E Ratio
- GRNQ N/A
- CLRB N/A
- Revenue Growth
- GRNQ 14.04
- CLRB N/A
- 52 Week Low
- GRNQ $0.84
- CLRB $2.71
- 52 Week High
- GRNQ $2.50
- CLRB $48.90
- Technical
- Relative Strength Index (RSI)
- GRNQ 56.40
- CLRB 33.08
- Support Level
- GRNQ $1.55
- CLRB $2.78
- Resistance Level
- GRNQ $1.88
- CLRB $3.15
- Average True Range (ATR)
- GRNQ 0.16
- CLRB 0.25
- MACD
- GRNQ 0.01
- CLRB 0.01
- Stochastic Oscillator
- GRNQ 68.73
- CLRB 16.83
About GRNQ Greenpro Capital Corp.
Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.